CURRENT LICENSEES:
Over-the-Counter Products Licensed to:
|
Licensed to Dermal Defense: Safe4Hours® Antibacterial/Antimicrobial Hand Sanitizers (1% Triclosan)
|
|
Safe4Hours® First Aid Antiseptic & Skin Protectant
|
|
Licensed DermSafe chlorhexidine hand sanitizer (For S.E. Asia)
|
|
Licensed DermSafe chlorhexidine hand sanitizer for commercial use in Canada
|
|
Licensed hemorrhoid cream (ProCort®)
|
Prescription Products Licensed to:
|
Embil Pharmaceuticals Co. Ltd.
Licensed prescription products: Clindamycin and Retinoic Acid used to treat acne
|
|
Laboratorios Panalab S.A
Licensed prescription products: Adapalene cream and gel used to treat acne
|
|
Latest Press Releases:
December 4, 2012
Skinvisible Granted US Patent for Topical Drug Delivery Technology
- Invisicare® Patent Protection Extends to Year 2029
November 27, 2012
Skinvisible Granted US Patent for Stabilizing Retinoids
- Intellectual Property Portfolio Strengthens
June 28, 2012
Skinvisible's Hand Sanitizer Kills "Super Bug" MRSA and E. coli For Up to 4 Hours
- Studies Confirm One Application of DermSafe As An Effective Long-Lasting Hand Sanitizer
April 12, 2012
Skinvisible Licensee Increases US Sales for Women's Health Product Made with Invisicare
- ProCort® Distribution Expands to Puerto Rico
March 7, 2012
Skinvisible Granted US Sunscreen Patent for UVA Absorber
- Broad Spectrum UVA / UVB Sunscreens with Invisicare Offer Eight Hours of Photostability
February 23, 2012
Skinvisible Formulation Submitted to European Union for Orphan Drug Designation
- Invisicare Formulation for Netherton Syndrome Under Review
CLICK HERE TO READ ALL NEWS RELEASES
Research & Development
Technology Overview
|
Skinvisible Web
